First Analysis
http://www.firstanalysis.com/index.asp?PID=16First Analysis is an investment organization specializing in private equity, venture capital, investment banking, and equity research. The sectors in the firm’s coverage universe include outsourced services, IT products and services, and chemistry-enabled businesses. First Analysis was founded in 1981.
View Older Stories View More Recent Stories
-
Diffusion Pharmaceuticals (DFFN) Says First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme
-
Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme
-
First Analysis Upgrades Anika Therapeutics (ANIK) to Overweight
-
Chrome River Closes 2017 with Record-breaking Revenue and Customer Growth
-
First Analysis Starts Catalent (CTLT) at Equal Weight, 'Drug Deliveries Technologies Leader' (Friday)
-
Diffusion Pharmaceuticals (DFFN) Commences Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme
-
Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme
-
Child Care Aware® of America's 11th Annual Cost of Care Report Shows Child Care Outpaces Nearly All Other Family Expenses Nationwide
-
MMRF Precision Medicine Model Drives New Discoveries in Multiple Myeloma
-
Tabula Rasa HealthCare Announces Pricing of Sale of Shares of Common Stock
-
Tabula Rasa HealthCare (TRHC) Announces 3M Share Offering
-
Tabula Rasa HealthCare Announces Proposed Offering of Common Stock
-
First Analysis Starts Callidus Software (CALD) at Equal Weight (Friday)
-
Pre-Open Movers 11/03: (ANET) (S) (WING) (JACK) Higher (P) (CBL) Lower (more...)
-
First Analysis Downgrades Pacific Biosciences of California (PACB) to Equal Weight
-
First Analysis Starts Tabula Rasa Healthcare (TRHC) at Overweight
-
First Analysis Downgrades Chegg (CHGG) to Equal Weight
-
First Analysis Downgrades LeMaitre Vascular (LMAT) to Equal Weight Citing Valuation
-
Satellite-Based Earth Observation Markets Continue to Soar
-
Blue Medora Closes $8M Series B1 Round of Venture Capital Funding
-
First Analysis Downgrades athenahealth (ATHN) to Equal Weight Citing Valuation
-
Analysis: Reports Of New York And Florida "Kratom Deaths" Are Unsupported By Facts
-
First Analysis Starts Quotient Technology (QUOT) at Overweight
-
First-Ever Analysis of Personalized Learning in Massachusetts Schools Reveals Need for More Professional Development and 24/7 Technology Access for Urban Students
-
ITA Hosts 5th Annual IoT Summit
-
ViralGains Attracts $13.5 Million Series B to Accelerate Growth of Industry's Only Ad Journey Platform
-
The Cookie Does Not Crumble: Engagement Labs' Newest TotalSocial(R) Rankings Reveal Consumer Conversation Trends for Top U.S. Food Brands Based on Word of Mouth and Social Media Conversations
-
JetBlue Hits Turbulence While Southwest Airlines Flies High
-
2u (TWOU) Prices 3,56M Share Common Offering at $49/Sh
-
2U, Inc. Announces Pricing of Public Offering of Common Stock
-
2u (TWOU) Announces 3M Share Public Offering of Common Stock
-
2U, Inc. Announces Public Offering of Common Stock
-
First Analysis Upgrades Palo Alto Networks (PANW) to Overweight
-
First Analysis Upgrades ChannelAdvisor (ECOM) to Overweight
-
Amgen (AMGN) Reports New Analysis on Repatha (evolocumab) Demonstrates Cardiovascular Outcomes Efficacy & Safety Of Achieving Very Low LDL-C Levels
-
New Repatha® (evolocumab) Analysis Demonstrates Cardiovascular Outcomes Efficacy And Safety Of Achieving Very Low LDL-C Levels
-
In wake of Foxconn deal, Wisconsin and Illinois vie for jobs
-
First Analysis Upgrades Intuit (INTU) to Equal Weight
-
First Analysis Upgrades Sharps Compliance (SMED) to Overweight
-
First Analysis Starts Coupa Software (COUP) at Overweight
-
First Analysis Downgrades New Relic (NEWR) to Equal Weight
-
First Analysis Upgrades Illumina (ILMN) to Equal Weight
-
WHOOP and Korey Stringer Institute Conduct Largest Athlete Performance Study to Date
-
First Analysis Downgrades MicroStrategy (MSTR) to Equal Weight
-
First Analysis Upgrades HealthStream (HSTM) to Equal Weight
-
Premier Expands Completion Workflows with NSI Technologies Acquisition
-
Form D First Analysis Fund XII
-
451 Research: Cloud Price Index Finds Serverless Usually Cheaper than Virtual Machines and Containers
-
Alnylam Pharma (ALNY) Announced New Positive Clinical Results for Givosiran (ALN-AS1)
-
Alnylam Reports New Positive Clinical Results for Givosiran (ALN-AS1), an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias

